Cargando…

Propionate and Alzheimer’s Disease

Propionate, a short-chain fatty acid, serves important roles in the human body. However, our review of the current literature suggests that under certain conditions, excess levels of propionate may play a role in Alzheimer’s disease (AD). The cause of the excessive levels of propionate may be relate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Killingsworth, Jessica, Sawmiller, Darrell, Shytle, R. Douglas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831739/ https://www.ncbi.nlm.nih.gov/pubmed/33505301 http://dx.doi.org/10.3389/fnagi.2020.580001

Ejemplares similares

Therapeutic Cocktail Approach for Treatment of Hyperhomocysteinemia in Alzheimer’s Disease
por: Leon, Michael, et al.
Publicado: (2018)

Beneficial effects of a pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer’s disease
por: Sawmiller, Darrell, et al.
Publicado: (2017)

The Immune System as a Therapeutic Target for Alzheimer’s Disease
por: Zieneldien, Tarek, et al.
Publicado: (2022)

LISPRO mitigates β-amyloid and associated pathologies in Alzheimer’s mice
por: Habib, Ahsan, et al.
Publicado: (2017)

Retraction Note to: LISPRO mitigates β-amyloid and associated pathologies in Alzheimer’s mice
por: Habib, Ahsan, et al.
Publicado: (2021)

Octyl Gallate Markedly Promotes Anti-Amyloidogenic Processing of APP through Estrogen Receptor-Mediated ADAM10 Activation
por: Zhang, She-Qing, et al.
Publicado: (2013)

Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain Injury
por: Sawmiller, Darrell, et al.
Publicado: (2014)

Targeting apolipoprotein E and N-terminal amyloid β-protein precursor interaction improves cognition and reduces amyloid pathology in Alzheimer’s mice
por: Sawmiller, Darrell, et al.
Publicado: (2023)

Propionate Protects Haloperidol-Induced Neurite Lesions Mediated by Neuropeptide Y
por: Hu, Minmin, et al.
Publicado: (2018)

Human Umbilical Cord Blood Serum–derived α-Secretase: Functional Testing in Alzheimer’s Disease Mouse Models
por: Habib, Ahsan, et al.
Publicado: (2018)

Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
por: Zhang, She-Qing, et al.
Publicado: (2013)

The role of heparan sulfate deficiency in autistic phenotype: potential involvement of Slit/Robo/srGAPs-mediated dendritic spine formation
por: Pérez, Christine, et al.
Publicado: (2016)

Chronic Kidney Disease in Propionic Acidemia
por: Shchelochkov, Oleg A., et al.
Publicado: (2019)

Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database
por: Lehrer, Steven, et al.
Publicado: (2018)

Matrix disequilibrium in Alzheimer’s disease and conditions that increase Alzheimer’s disease risk
por: Amontree, Matthew, et al.
Publicado: (2023)

Alzheimer Disease and Selected Risk Factors Disrupt a Co-regulation of Monoamine Oxidase-A/B in the Hippocampus, but Not in the Cortex
por: Quartey, Maa O., et al.
Publicado: (2018)

Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted Approaches
por: Galasko, Douglas
Publicado: (2015)

Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease β-amyloid production
por: Rezai-Zadeh, Kavon, et al.
Publicado: (2009)

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease
por: Sumner, Isabelle L., et al.
Publicado: (2018)

Biological and disease hallmarks of Alzheimer’s disease defined by Alzheimer’s disease genes
por: Murakami, Shin, et al.
Publicado: (2022)

Testosterone Propionate Exacerbates the Deficits of Nigrostriatal Dopaminergic System and Downregulates Nrf2 Expression in Reserpine-Treated Aged Male Rats
por: Cui, Rui, et al.
Publicado: (2017)

Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer’s mice
por: Li, Song, et al.
Publicado: (2015)

Alzheimer's Disease and Anesthesia
por: Papon, Marie-Amélie, et al.
Publicado: (2011)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Rethinking Alzheimer’s Disease
por: de Mendonça, Alexandre
Publicado: (2012)

Alzheimer’s disease and the fornix
por: Oishi, Kenichi, et al.
Publicado: (2014)

Alzheimer's disease and the microbiome
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2013)

Epigenetics in Alzheimer’s Disease
por: Gao, Xiaodie, et al.
Publicado: (2022)

NPTX2 and cognitive dysfunction in Alzheimer’s Disease
por: Xiao, Mei-Fang, et al.
Publicado: (2017)

High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease
por: Bester, Janette, et al.
Publicado: (2013)

Speaking in Alzheimer’s Disease, is That an Early Sign? Importance of Changes in Language Abilities in Alzheimer’s Disease
por: Szatloczki, Greta, et al.
Publicado: (2015)

Validation of the Alzheimer’s disease-resemblance atrophy index in classifying and predicting progression in Alzheimer’s disease
por: He, Qiling, et al.
Publicado: (2022)

Evaluation of Fluticasone Propionate and Fluticasone Propionate/Salmeterol Combination on Exercise in Pediatric and Adolescent Patients with Asthma
por: Murray, John J, et al.
Publicado: (2011)

The Impact of Disease Comorbidities in Alzheimer's Disease
por: Santiago, Jose A., et al.
Publicado: (2021)

Ketamine: A Neglected Therapy for Alzheimer Disease
por: Smalheiser, Neil R.
Publicado: (2019)

Retinal Vasculopathy in Alzheimer’s Disease
por: Shi, Haoshen, et al.
Publicado: (2021)

Reassessment of Pioglitazone for Alzheimer’s Disease
por: Saunders, Ann M., et al.
Publicado: (2021)

Implications of Glycosylation in Alzheimer’s Disease
por: Haukedal, Henriette, et al.
Publicado: (2021)

Cystatin C in Alzheimer's disease
por: Kaur, Gurjinder, et al.
Publicado: (2012)

Calcium and Neurogenesis in Alzheimer's Disease
por: Wang, Jun Ming, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7s47ggk6nsuv30pva4f5ertr4e